Matches in SemOpenAlex for { <https://semopenalex.org/work/W4207079248> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4207079248 endingPage "76" @default.
- W4207079248 startingPage "76" @default.
- W4207079248 abstract "BACKGROUND: The identification of aberrant phenotypes in acute leukemia is crucial for treatment monitoring and minimal residual disease analysis. Flowcytometric immunophenotyping in acute leukemia is an important tool for the detection of these aberrancies. There is wide variation in the incidence of aberrant antigens in acute leukemia in different studies and its correlation with prognostic markers.AIMS AND OBJECTIVES: The aim and objective of this study is to assess the frequency of aberrant markers in acute leukemia and determine any association with hematological parameters.MATERIALS AND METHODS: A total of 150 newly diagnosed cases of acute leukemia during the period January 2018–December 2020 were included. The flowcytometric immunophenotyping of all the above cases was done using BD FACS Canto II.RESULTS: Out of the total 150 cases of acute leukemia, 56.7% expressed aberrant phenotype. The proportional frequency of aberrant antigen expression in B-acute lymphoid leukemia (ALL), T-ALL and acute myeloid leukemia (AML) was 56.6%, 50%, and 58.5%, respectively. CD13, CD13, and CD7 were the most common aberrancies in B-ALL, T-ALL, and AML, respectively. Aberrant myeloid phenotype in B-ALL was associated with lower mean total leukocyte count (TLC) and blast percentage in peripheral blood as compared to the B-ALL with conventional phenotypes. Aberrant lymphoid phenotype in AML was associated with a higher TLC and greater blast percentage in peripheral blood than the AML with conventional phenotypes.CONCLUSION: Aberrant lymphoid phenotype in AML is associated with unfavorable hematological features. However, aberrant myeloid phenotype in B-ALL is not associated with adverse features." @default.
- W4207079248 created "2022-01-26" @default.
- W4207079248 creator A5060868746 @default.
- W4207079248 creator A5067674349 @default.
- W4207079248 date "2022-01-01" @default.
- W4207079248 modified "2023-09-26" @default.
- W4207079248 title "Spectrum of immunophenotypic aberrancies in acute leukemia along with their correlation with adverse hematological parameters" @default.
- W4207079248 cites W1543774298 @default.
- W4207079248 cites W1590892037 @default.
- W4207079248 cites W1970477403 @default.
- W4207079248 cites W1996849272 @default.
- W4207079248 cites W2013787055 @default.
- W4207079248 cites W2014838976 @default.
- W4207079248 cites W2076547855 @default.
- W4207079248 cites W2324656831 @default.
- W4207079248 cites W2506008922 @default.
- W4207079248 cites W2792055125 @default.
- W4207079248 cites W2917700400 @default.
- W4207079248 cites W3133723967 @default.
- W4207079248 doi "https://doi.org/10.4103/kleuhsj.kleuhsj_170_21" @default.
- W4207079248 hasPublicationYear "2022" @default.
- W4207079248 type Work @default.
- W4207079248 citedByCount "1" @default.
- W4207079248 countsByYear W42070792482023 @default.
- W4207079248 crossrefType "journal-article" @default.
- W4207079248 hasAuthorship W4207079248A5060868746 @default.
- W4207079248 hasAuthorship W4207079248A5067674349 @default.
- W4207079248 hasBestOaLocation W42070792481 @default.
- W4207079248 hasConcept C104317684 @default.
- W4207079248 hasConcept C127716648 @default.
- W4207079248 hasConcept C142724271 @default.
- W4207079248 hasConcept C147483822 @default.
- W4207079248 hasConcept C196166836 @default.
- W4207079248 hasConcept C203014093 @default.
- W4207079248 hasConcept C2776863199 @default.
- W4207079248 hasConcept C2778461978 @default.
- W4207079248 hasConcept C2778729363 @default.
- W4207079248 hasConcept C2779282312 @default.
- W4207079248 hasConcept C2779823535 @default.
- W4207079248 hasConcept C54355233 @default.
- W4207079248 hasConcept C71924100 @default.
- W4207079248 hasConcept C86803240 @default.
- W4207079248 hasConceptScore W4207079248C104317684 @default.
- W4207079248 hasConceptScore W4207079248C127716648 @default.
- W4207079248 hasConceptScore W4207079248C142724271 @default.
- W4207079248 hasConceptScore W4207079248C147483822 @default.
- W4207079248 hasConceptScore W4207079248C196166836 @default.
- W4207079248 hasConceptScore W4207079248C203014093 @default.
- W4207079248 hasConceptScore W4207079248C2776863199 @default.
- W4207079248 hasConceptScore W4207079248C2778461978 @default.
- W4207079248 hasConceptScore W4207079248C2778729363 @default.
- W4207079248 hasConceptScore W4207079248C2779282312 @default.
- W4207079248 hasConceptScore W4207079248C2779823535 @default.
- W4207079248 hasConceptScore W4207079248C54355233 @default.
- W4207079248 hasConceptScore W4207079248C71924100 @default.
- W4207079248 hasConceptScore W4207079248C86803240 @default.
- W4207079248 hasIssue "1" @default.
- W4207079248 hasLocation W42070792481 @default.
- W4207079248 hasLocation W42070792482 @default.
- W4207079248 hasOpenAccess W4207079248 @default.
- W4207079248 hasPrimaryLocation W42070792481 @default.
- W4207079248 hasRelatedWork W2041569392 @default.
- W4207079248 hasRelatedWork W2070211962 @default.
- W4207079248 hasRelatedWork W2080925159 @default.
- W4207079248 hasRelatedWork W2150998544 @default.
- W4207079248 hasRelatedWork W2352094097 @default.
- W4207079248 hasRelatedWork W2352358519 @default.
- W4207079248 hasRelatedWork W2393383561 @default.
- W4207079248 hasRelatedWork W2461073212 @default.
- W4207079248 hasRelatedWork W2988833721 @default.
- W4207079248 hasRelatedWork W3030698952 @default.
- W4207079248 hasVolume "15" @default.
- W4207079248 isParatext "false" @default.
- W4207079248 isRetracted "false" @default.
- W4207079248 workType "article" @default.